MedTrace Logo

Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children

NCT00981877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2009-09-22

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of probiotics in rotavirus acute diarrhea in children. The investigators will compare the effect of two different probiotics products.

Conditions

Interventions

DRUG

GB (Florestor)

S. Boulardii preparation of 1 gram twice daily for 5 days

DRUG

GRALB

mixed probiotic preparation 1 gram twice daily for 5 days.

DRUG

GC (placebo)

Placebo 1 gram twice daily for 5 days.

Sponsors & Collaborators

  • Instituto de Nutrición y Tecnología de los Alimentos

    collaborator OTHER

  • Centro Pediatrico Albina de Patino

    lead OTHER

Principal Investigators

  • Richard M Soria, MD · Centro Pediatrico Albina Patino

  • Giuseppe E Grandy, Md · Centro Pediatrico Albina Patino - Instituto de Nutricion y Tecnologia de los Alimentos

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
23 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Bolivia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00981877 on ClinicalTrials.gov